stella
beta
A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma. — Stella
Recruiting
Back to Melanoma (Skin Cancer) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
Belgium
UZ Brussel, Jette, Brussels Capital
View full record on ClinicalTrials.gov